U.S. based Advent International is poised to complete a takeover of Central and Eastern European drug maker Ozone. The companies are now in the final talks that would give Advent, also the owner of LaborMed, full ownership of Ozone's product lines. The buyout offer had been accepted by Ozone earlier this month, giving control of the company's portfolio to LaborMed.